M. Khoshnejad

发表

Immunogenicity of a DNA vaccine candidate for COVID-19

J. Kim, D. Weiner, Jian Yan, 2020, Nature Communications.

Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging.

C. Villa, V. Muzykantov, C. Greineder, 2018, Bioconjugate chemistry.

Ferritin‐based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting

V. Muzykantov, H. Parhiz, I. Dmochowski, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.

Colin F Greineder, Vladimir R Muzykantov, Andrew Tsourkas, 2017, Bioconjugate chemistry.

Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.

V. Muzykantov, C. Greineder, M. Poncz, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.

V. Muzykantov, C. Greineder, I. Dmochowski, 2016, Bioconjugate chemistry.

Synthetic Antibodies: The Emerging Field of Aptamers

M. Khoshnejad, Suzy Kedzierski, G. Caltagirone, 2013 .

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

Samir Mitragotri, Vladimir Muzykantov, Hamideh Parhiz, 2018, Nature Communications.

Rapid development of a synthetic DNA vaccine for COVID-19

Daniel W. Kulp, J. Kim, D. Weiner, 2020 .

Size and targeting to PECAM vs ICAM control endothelial delivery, internalization and protective effect of multimolecular SOD conjugates.

V. Muzykantov, S. Muro, M. Khoshnejad, 2016, Journal of controlled release : official journal of the Controlled Release Society.

CRISPR/Cas9-Mediated Genetic Engineering of Hybridomas for Creation of Antibodies that Allow for Site-Specific Conjugation.

V. Muzykantov, H. Parhiz, M. Khoshnejad, 2019, Methods in molecular biology.

Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo

D. Weiner, Ami Patel, Xizhou Zhu, 2020, Molecular therapy. Methods & clinical development.

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens

J. Kim, D. Weiner, A. Srinivasan, 2021, Genes & cancer.

Immunogenicity of a DNA vaccine candidate for COVID-19

Daniel W. Kulp, J. Kim, D. Weiner, 2020, Nature Communications.

Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody

D. Weiner, S. Kudchodkar, K. Ugen, 2020, Human vaccines & immunotherapeutics.

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics

D. Rader, D. Weiner, S. Kudchodkar, 2018, Molecular Therapy.

Unintended effects of drug carriers: Big issues of small particles

V. Muzykantov, H. Parhiz, J. Myerson, 2018, Advanced drug delivery reviews.

Peptide-Based Subunit Vaccine against Hookworm Infection

A. Loukas, M. Skwarczynski, I. Toth, 2012, PloS one.

PECAM‐1 directed re‐targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E‐mediated uptake

Hamideh Parhiz, D. Weissman, V. Muzykantov, 2018, Journal of controlled release : official journal of the Controlled Release Society.

DNA-Encoded Glutamine Synthetase Enzyme as Ammonia-Lowering Therapeutic for Hyperammonemia.

D. Weiner, Ami Patel, Xizhou Zhu, 2020, Nucleic acid therapeutics.

Spatially controlled assembly of affinity ligand and enzyme cargo enables targeting ferritin nanocarriers to caveolae.

Vladimir R Muzykantov, V. Muzykantov, R. Stan, 2018, Biomaterials.

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

J. Lahann, S. Mitragotri, C. Villa, 2018, Nature Communications.

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier

C. Villa, V. Muzykantov, C. Greineder, 2020, Proceedings of the National Academy of Sciences.

Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases.

S. Kudchodkar, J. Maslow, M. Jeong, 2021, Methods in molecular biology.

Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9

C. Villa, V. Muzykantov, C. Greineder, 2018, Scientific Reports.

Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9

C. Villa, V. Muzykantov, C. Greineder, 2018, Scientific Reports.